Adenosine A1 receptor agonist, N6-cyclohexyladenosine, attenuates Huntington's disease via stimulation of TrKB/PI3K/Akt/CREB/BDNF pathway in 3-nitropropionic acid rat model
Heba I. Ibrahim, Mostafa A. Rabie, Reham A. Mohamed, Noha N. Nassar
Topics & Concepts
NeuroprotectionTropomyosin receptor kinase BCREBChemistryPI3K/AKT/mTOR pathwayNeurodegenerationAgonistProtein kinase BAdenosine A2A receptorGlial fibrillary acidic proteinAdenosineGlutamate receptorEndocrinologyOxidative stressPharmacologyInternal medicineAdenosine receptorReceptorBiologyMedicineNeurotrophic factorsSignal transductionBiochemistryTranscription factorGeneImmunohistochemistryDiseaseGenetic Neurodegenerative DiseasesNeuroscience and Neuropharmacology ResearchNeurological disorders and treatments